Transcatheter Mitral Valve Implantation (TMVI)

The FORTIS transcatheter mitral valve (Edwards Lifesciences, Irvine, CA, USA) is a self-expanding device implanted via a transapical approach that is currently undergoing first-in-man trials. Below is a link to the paper with the latest evidence on the device and a link to the news release.

Bapat et al. 2014 Eurointervention

Edwards News Release

X0000_Edwards_Fortis transcatheter Mitral valve copy_0

About The Author

SHDA is supported by

Subscribe

Recent Tweets

Upcoming Meetings

july

04julAll Day06AICT-AsiaPCR 2019

25jul(jul 25)10:00 am26(jul 26)5:00 pmWorld Congress on Cardiology and Critical Care

X